TY - JOUR
T1 - Generalized lipodystrophy
T2 - In vivo evidence for hypermetabolism and insulin-resistant lipid, glucose, and amino acid kinetics
AU - Klein, Samuel
AU - Jahoor, Farook
AU - Wolfe, Robert R.
AU - Stuart, Charles A.
N1 - Funding Information:
From the Departments of Internal Medicine, Preventive Medicine, and Community Health, Surgery, and Anesthesiology, The University of Texas Medical Branch and The Shnmers Bums Institute, Galveston, TX Supported by National Institutes of Health Grant No. CA 50330, Clinical Research Grant No. RR-00073, and a grantf rom the Shriners Hospitals. Address reprint requests to Samuel Klein, MD, Division of Gastroenterology G-64, The University of Texas Medical Branch, Galveston, TX 77550. Copyright 0 I992 by W B. Saunders Company 0026-0495/92/4108-0015$03.00/0
PY - 1992/8
Y1 - 1992/8
N2 - Stable isotope tracers and indirect calorimetry were used to evaluate whole-body energy, glucose, lipid, and amino acid metabolism in a patient with generalized lipodystrophy during basal conditions and in response to insulin therapy. The results were compared with those obtained in previous studies in normal volunteers. The basal rate of glucose production (33.7 μmol/kg·min) was three times higher than normal. The basal rate of glycerol appearance in blood, an index of lipolysis, was 60% greater than normal when expressed per kilogram body weight (3.82 μmol/kg·min), but was more than 10 times normal when expressed per kilogram body fat mass (123.2 μmol/kg·min) because of the marked decrease in body fat in our patient (3% of total body weight). Leucine rate of appearance, an index of protein breakdown, and nonoxidative leucine disposal, an index of protein synthesis, were also greater than normal. Resting energy expenditure (REE) was 30% greater than normal. The effect of insulin infusion on these metabolic parameters was markedly blunted. These metabolic abnormalities help explain many of the clinical findings such as hyperglycemia, hypertriglyceridemia, fat depletion, hepatomegaly, and steatosis observed in patients with lipodystrophy. Ineffective insulin function in many tissues appears to be an important factor in the pathophysiology of lipodystrophy.
AB - Stable isotope tracers and indirect calorimetry were used to evaluate whole-body energy, glucose, lipid, and amino acid metabolism in a patient with generalized lipodystrophy during basal conditions and in response to insulin therapy. The results were compared with those obtained in previous studies in normal volunteers. The basal rate of glucose production (33.7 μmol/kg·min) was three times higher than normal. The basal rate of glycerol appearance in blood, an index of lipolysis, was 60% greater than normal when expressed per kilogram body weight (3.82 μmol/kg·min), but was more than 10 times normal when expressed per kilogram body fat mass (123.2 μmol/kg·min) because of the marked decrease in body fat in our patient (3% of total body weight). Leucine rate of appearance, an index of protein breakdown, and nonoxidative leucine disposal, an index of protein synthesis, were also greater than normal. Resting energy expenditure (REE) was 30% greater than normal. The effect of insulin infusion on these metabolic parameters was markedly blunted. These metabolic abnormalities help explain many of the clinical findings such as hyperglycemia, hypertriglyceridemia, fat depletion, hepatomegaly, and steatosis observed in patients with lipodystrophy. Ineffective insulin function in many tissues appears to be an important factor in the pathophysiology of lipodystrophy.
UR - http://www.scopus.com/inward/record.url?scp=0026650829&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(92)90173-8
DO - 10.1016/0026-0495(92)90173-8
M3 - Article
C2 - 1640869
AN - SCOPUS:0026650829
SN - 0026-0495
VL - 41
SP - 893
EP - 896
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 8
ER -